Stay updated on Carboplatin/Etoposide +/- Atezolizumab & Trilaciclib Clinical Trial
Sign up to get notified when there's something new on the Carboplatin/Etoposide +/- Atezolizumab & Trilaciclib Clinical Trial page.

Latest updates to the Carboplatin/Etoposide +/- Atezolizumab & Trilaciclib Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe record history now includes a new revision entry Revision: v3.5.4, indicating a newer update to the page. The prior revision entry Revision: v3.5.3 has been removed from the history.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedNew revision entry v3.5.3 was added to the revision history, replacing the prior v3.5.2. This represents an update to the page’s revision record, reflecting an updated version of the page metadata.SummaryDifference0.1%

- Check40 days agoChange DetectedRevision history now shows an addition of v3.5.2 and a deletion of v3.5.0.SummaryDifference0.1%

- Check69 days agoChange DetectedA new revision entry v3.5.0 was added to the record history. The previous revision v3.4.3 was removed.SummaryDifference0.1%

- Check76 days agoChange DetectedAdded revision label v3.4.3 and removed revision label v3.4.2 from the record history.SummaryDifference0.1%

- Check105 days agoChange DetectedAdded a new revision entry, Revision: v3.4.2, to the study record history. Removed older administrative notices including the government funding lapse alert and the Revision: v3.4.1 entry.SummaryDifference0.6%

Stay in the know with updates to Carboplatin/Etoposide +/- Atezolizumab & Trilaciclib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carboplatin/Etoposide +/- Atezolizumab & Trilaciclib Clinical Trial page.